NO901659L - Trombolytisk aktivatorkompleks og dets fremstilling. - Google Patents

Trombolytisk aktivatorkompleks og dets fremstilling.

Info

Publication number
NO901659L
NO901659L NO90901659A NO901659A NO901659L NO 901659 L NO901659 L NO 901659L NO 90901659 A NO90901659 A NO 90901659A NO 901659 A NO901659 A NO 901659A NO 901659 L NO901659 L NO 901659L
Authority
NO
Norway
Prior art keywords
thrombolytic
preparation
activator complex
activator
complex
Prior art date
Application number
NO90901659A
Other languages
English (en)
Other versions
NO901659D0 (no
Inventor
Victor Gurewich
Jerome Breton
Original Assignee
Vascular Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vascular Lab filed Critical Vascular Lab
Publication of NO901659D0 publication Critical patent/NO901659D0/no
Publication of NO901659L publication Critical patent/NO901659L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
NO90901659A 1989-04-13 1990-04-11 Trombolytisk aktivatorkompleks og dets fremstilling. NO901659L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33732189A 1989-04-13 1989-04-13
US49821090A 1990-03-23 1990-03-23

Publications (2)

Publication Number Publication Date
NO901659D0 NO901659D0 (no) 1990-04-11
NO901659L true NO901659L (no) 1990-10-15

Family

ID=26990640

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90901659A NO901659L (no) 1989-04-13 1990-04-11 Trombolytisk aktivatorkompleks og dets fremstilling.

Country Status (7)

Country Link
EP (1) EP0395918A3 (no)
JP (1) JPH03117484A (no)
CN (1) CN1049865A (no)
AU (1) AU5316290A (no)
CA (1) CA2014470A1 (no)
FI (1) FI901810A7 (no)
NO (1) NO901659L (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612034A (en) * 1990-10-03 1997-03-18 Redcell, Inc. Super-globuling for in vivo extended lifetimes
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
FR2686900B1 (fr) * 1992-01-31 1995-07-21 Rhone Poulenc Rorer Sa Nouveaux polypeptides ayant une activite de stimulation des colonies de granulocytes, leur preparation et compositions pharmaceutiques les contenant.
EP0682700A4 (en) * 1993-02-05 1997-05-28 Vascular Lab USE OF UROKINASE-LIKE PLASMINOGEN ACTIVATORS IN THE INTERIOR OF PLATES FOR THE LONG-TERM INHIBITION OF THROMBOSE.
ES2066733B1 (es) * 1993-06-30 1995-11-01 Antibioticos Farma S A Complejo consistente en un activador del plasminogeno y albumina de suero y procedimiento para prepararlo.
US5759542A (en) * 1994-08-05 1998-06-02 New England Deaconess Hospital Corporation Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
US5840733A (en) 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
JP2003530838A (ja) 2000-04-12 2003-10-21 ヒューマン ゲノム サイエンシズ インコーポレイテッド アルブミン融合タンパク質
JP4706093B2 (ja) * 2000-09-25 2011-06-22 富士レビオ株式会社 パルボウイルスの除去方法及び精製方法
CA2440582A1 (en) 2001-03-09 2002-10-03 Dyax Corp. Serum albumin binding moieties
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
ES2425738T3 (es) 2001-12-21 2013-10-17 Human Genome Sciences, Inc. Proteínas de fusión de la albúmina
US7041790B2 (en) 2002-03-26 2006-05-09 Dyax Corp. Fibrinogen binding moieties
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
JP2008512385A (ja) * 2004-09-03 2008-04-24 アルザ コーポレイション アルブミンの内因的に形成された結合体
GB0803068D0 (en) * 2008-02-20 2008-03-26 Health Prot Agency Cross-linked biological indicator
CN105148261A (zh) * 2008-03-31 2015-12-16 苏州兰鼎生物制药有限公司 尿激酶原及尿激酶原变体在急性心肌梗塞易化经皮冠状动脉介入中的应用
CN101260145B (zh) * 2008-04-11 2012-08-08 天津溥瀛生物技术有限公司 一种重组人血清白蛋白及其融合蛋白的分离纯化工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400653D0 (en) * 1984-01-11 1984-02-15 Beecham Group Plc Conjugates
GB8430252D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
KR940003056B1 (ko) * 1985-04-16 1994-04-13 가부시끼가이샤 미도리 쥬우지 우로키나제 전구체를 안정화시키는 방법

Also Published As

Publication number Publication date
EP0395918A2 (en) 1990-11-07
JPH03117484A (ja) 1991-05-20
CN1049865A (zh) 1991-03-13
FI901810A7 (fi) 1990-10-14
FI901810A0 (fi) 1990-04-10
EP0395918A3 (en) 1991-10-23
CA2014470A1 (en) 1990-10-13
AU5316290A (en) 1990-10-18
NO901659D0 (no) 1990-04-11

Similar Documents

Publication Publication Date Title
NO901659L (no) Trombolytisk aktivatorkompleks og dets fremstilling.
DE69012888D1 (de) Plasminogenaktivator.
DK609689A (da) Folielaminat og dets anvendelse
DK656189D0 (da) Stabiliseret sucralosekompleks, dets fremstilling og anvendelse
NO872729D0 (no) Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
NO901381L (no) Blanding og anvendelse.
NO902658D0 (no) N-fenylpyrazolderivater, preparater og anvendelse derav.
DK202687A (da) Vaevs-plasminogen-aktivator (tpa)-derivat og dets fremstilling
DK432289A (da) Vandfortyndbart, lufttoerende belaegningsmiddel og dets anvendelse
NO175373C (no) Heteropolysakkarid, fremgangsmåte for dets fremstilling og anvendelse
NO171591C (no) Forbindelse, biocid blanding og anvendelse
DE69011337D1 (de) Polyhalodihydrodioxine und polyhalodioxole.
DK525687A (da) Enzymholdigt praeparat, dets fremstilling og anvendelse
NO894350L (no) Pyrrolokinolin- og pyrrolofenotiazinkarboksamider og beslektede forbindelser.
DK296687D0 (da) N-1h-tetrazol-5-yl-2-thiophen-carboxamider, n-1h-tetrazol-5-yl-2-pyrrol-carboxamider og n-1h-tetrazol-5-yl-2-furan-carboxamider
FI873879L (fi) Lymfocyter aktiverande polypeptider.
NO903675L (no) Aminfrie forestrede glycidyleter-addisjonsprodukter og anvendelse derav.
NO904113D0 (no) Aminofosfinater og blandinger inneholdende slike.
DK125087A (da) Efomycin g., dets fremstilling og anvendelse
NO900271D0 (no) Forbindelse og anvendelse.
DK367189A (da) T-pa-derivat og dets fremstilling
NO901052L (no) 1h-pyrazol-1-acetamider og fremstilling derav.
NO174896C (no) Oppvaskmiddel og dets anvendelse
DK690587D0 (da) Tetrapeptid, dets fremstilling og anvendelse
DK51089A (da) Et antibiotikum, cammunocin, dets fremstilling og anvendelse